Thyroid cancer: open trials in Japan

• NCT05786924

  Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

  Trial Treatment · Phase 1/2 · Institut de Recherches Internationales Servier

  Kanagawa Cancer Center, Kanagawa · Kyoto University Hospital, Kyoto · National Cancer Center Hospital, Tokyo

  Registry updated 2026-10-13

• NCT07006727

  Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors

  Trial Treatment · Phase 1 · Novartis Pharmaceuticals

  Chuo Ku

  Registry updated 2026-09-22

• NCT07521670

  Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)

  Trial Treatment · Phase 2 · National Cancer Centre, Singapore

  National Cancer Center Hospital, Tokyo

  Registry updated 2026-07-15

• NCT03093116

  A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  Trial Treatment · Phase 1/2 · Turning Point Therapeutics, Inc.

  National Cancer Center Hospital, Chuo Ku · National Cancer Center Hospital East, Kashiwa · Nagoya University Hospital, Nagoya · Osaka City General Hospital, Osaka · Osaka International Cancer Institute, Osaka · Hokkaido University Hospital, Sapporo · Ehime University Hospital, Tōon · Kanagawa Cancer Center, Yokohama · Tottori University Hospital, Yonago

  Registry updated 2026-05-27

• NCT07287748

  A Phase I Trial of Af-001 in Patients With Differentiated Thyroid Cancer

  Trial Treatment · Phase 1 · Alpha Fusion Inc.

  National Cancer Center Hospital East, Kashiwa

  Registry updated 2025-12-31

All Thyroid cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error